Literature DB >> 1547843

The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis.

H Chart1, O A Okubadejo, B Rowe.   

Abstract

Sera from ten patients with positive brucella serology were used to investigate antibody cross-reactions between the O-antigens of Escherichia coli O157 and Yersinia enterocolitica O9. SDS-PAGE profiles of lipopolysaccharide (LPS), purified from strains of E. coli O157 and Y. enterocolitica O9, were reacted with sera by immunoblotting. All ten sera contained antibodies which bound to the LPS of E. coli O157, and five of these sera also contained antibodies which bound to the LPS of Y. enterocolitica O9. Absorption studies using these five cross-reacting sera indicated the existence of at least three epitopes exposed on the O-antigens of E. coli O157 and Y. enterocolitica O9. One antigen binding site appeared to be exposed on the LPS of both organisms, while one epitope was exposed on the LPS of E. coli O157 only, and another on the LPS of Y. enterocolitica O9 only.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547843      PMCID: PMC2272183          DOI: 10.1017/s0950268800049529

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

1.  Purification of lipopolysaccharide from strains of Yersinia enterocolitica belonging to serogroups 03 and 09.

Authors:  H Chart; B Rowe
Journal:  FEMS Microbiol Lett       Date:  1991-01-15       Impact factor: 2.742

2.  Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome.

Authors:  H Chart; S M Scotland; H R Smith; B Rowe
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

3.  Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus.

Authors:  R H Notenboom; A Borczyk; M A Karmali; L M Duncan
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

4.  Identification of a serological cross-reaction between Brucella abortus and Escherichia coli 0:157.

Authors:  F A Stuart; M J Corbel
Journal:  Vet Rec       Date:  1982-02-27       Impact factor: 2.695

5.  Naturally occurring antibodies in human sera that react with the iron-regulated outer membrane proteins of Escherichia coli.

Authors:  E Griffiths; P Stevenson; R Thorpe; H Chart
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

6.  Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7.

Authors:  M B Perry; L MacLean; D W Griffith
Journal:  Biochem Cell Biol       Date:  1986-01       Impact factor: 3.626

7.  Immunochemical studies on a Yersinia enterocolitica O:9 lipopolysaccharide cross-reacting with Brucella abortus and Vibrio cholerae extracts.

Authors:  R Sandulache; A Marx
Journal:  Ann Microbiol (Paris)       Date:  1978-10

8.  Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.

Authors:  H Chart; H R Smith; S M Scotland; B Rowe; D V Milford; C M Taylor
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

9.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

Review 10.  Hemolytic uremic syndrome.

Authors:  M Levin; M D Walters; T M Barratt
Journal:  Adv Pediatr Infect Dis       Date:  1989
View more
  14 in total

1.  Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.

Authors:  J Evans; R M Chalmers; H Chart; R L Salmon; S M Kench; T J Coleman; D Meadows; P Morgan-Capner; P Softley; M Sillis; D R Thomas
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Peptidoglycan remodeling and conversion of an inner membrane into an outer membrane during sporulation.

Authors:  Elitza I Tocheva; Eric G Matson; Dylan M Morris; Farshid Moussavi; Jared R Leadbetter; Grant J Jensen
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

3.  Development of primers to O-antigen biosynthesis genes for specific detection of Escherichia coli O157 by PCR.

Authors:  J J Maurer; D Schmidt; P Petrosko; S Sanchez; L Bolton; M D Lee
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

4.  Afipia clevelandensis antibodies and cross-reactivity with Brucella spp. and Yersinia enterocolitica O:9.

Authors:  M Drancourt; P Brouqui; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

5.  Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.

Authors:  D Reymond; R P Johnson; M A Karmali; M Petric; M Winkler; S Johnson; K Rahn; S Renwick; J Wilson; R C Clarke; J Spika
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.

Authors:  J Xu; Y Qiu; M Cui; Y Ke; Q Zhen; X Yuan; Y Yu; X Du; J Yuan; H Song; Z Wang; G Gao; S Yu; Y Wang; L Huang; Z Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-15       Impact factor: 3.267

7.  Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Authors:  Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

8.  Coincidence of acute brucella hepatitis and dengue fever or serologic cross-reactivity?

Authors:  Khalid I Bzeizi; Ali Benmousa; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

9.  Antibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.

Authors:  Armando Navarro; Carlos Eslava; Ulises Hernandez; Jose Luis Navarro-Henze; Magali Aviles; Guadalupe Garcia-de la Torre; Alejandro Cravioto
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis.

Authors:  Sarah L Keasey; Kara E Schmid; Michael S Lee; James Meegan; Patricio Tomas; Michael Minto; Alexander P Tikhonov; Barry Schweitzer; Robert G Ulrich
Journal:  Mol Cell Proteomics       Date:  2008-12-27       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.